Skip to content

Clinical trials

Multiple Myeloma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Singapore Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20081
20093
20125
20132
20145
20151
20161
20181
20191
20201
20211
20222
20234
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting5
Unknown status5
Active, not recruiting3
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
National University Hospital, Singapore4
Amgen3
Singapore General Hospital3
Takeda3
Bristol-Myers Squibb2
Janssen Research & Development, LLC2
AbbVie1
AstraZeneca1
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma34
Recurrence7
Neoplasms, Plasma Cell4
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Amyloidosis1
Blood Protein Disorders1
Bone Diseases1

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.